CD9 and gastric cancer: Similarly, Hori et al. (2004) and Soyuer et al. (2010) described that higher CD9 expression was associated with more aggressive tumors and increased number of lymph node metastases in gastric cancers, therefore representing a marker of poor prognosis [60,61].